IMIvan Muñoz

Ivan Muñoz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ivan Muñoz has a total of 89 co-authors. Here are the top co-authors by number of shared publications:

  • John Rouse

    MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, DD1 5EH

    9 shared publications
  • Joaquín Ariño

    Institut de Biotecnologia i Biomedicina & Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain

    8 shared publications
  • Amparo Ruiz

    Center for Biomedical Imaging, Department of Radiology New York University Grossman School of Medicine New York New York USA

    5 shared publications
  • Rachel Toth

    MRC Reagents and Services School of Life Sciences University of Dundee Dundee UK

    4 shared publications
  • Asier González

    Institut de Biotecnologia i Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra 08193, Barcelona, Spain

    3 shared publications
  • Florian Weiland

    Laboratory of Enzyme, Fermentation and Brewing Technology, Department of Microbial and Molecular Systems (M2S), KU Leuven, Ghent Campus, Gebroeders de Smetstraat 1, 9000 Ghent, Belgium

    3 shared publications

Latest Publications

  • Open Access

    A PLK1-Directed Mitotic Genome Maintenance Network Promotes DNA Synthesis in Mitosis

    by Daniel-Cristian Ungureanu, Ivan Muñoz, Wissem Bououdina, Szymon A. Barwacz, Thomas Macartney, Frederic Lamoliatte, Yixin Wang, Ying Liu, Florian Weiland, John Rouse

    Polo-like kinase 1 (PLK1) is a master regulator of mitosis and is known to dictate DNA repair pathway choice at this stage of the cell cycle. However, its roles in controlling mitotic DNA damage responses remain incompletely characterised. Here, we used acute PLK1 inhibition as a substrate-trapping strategy to stabilise PLK1–target interactions in mitotic cells and identify PLK1-associated DNA repair factors. Proteomic analysis of endogenous HA-tagged PLK1 complexes revealed interactions with multiple genome stability proteins, including SLX4, RAD52, FANCM, and REV1. We demonstrate that PLK1 binds SLX4 and RAD52 via canonical CDK1-dependent phospho-docking motifs centred on SLX4 Ser1453 and RAD52 Thr300. Mutation of these residues abolished PLK1 binding and, at least for RAD52, prevented PLK1-dependent phosphorylation of mitotic targets. Functional analyses showed that PLK1 docking to SLX4 is dispensable for interstrand crosslink repair but essential for mitotic DNA synthesis (MiDAS), defining a separation-of-function allele. Likewise, disruption of PLK1 docking to RAD52 impaired MiDAS. Together, these findings identify PLK1 as a key coordinator of mitotic genome maintenance pathways required for MiDAS.

  • Open Access

    Nek1 defines a branch of centriolar microtubule length control parallel to CP110-Cep97

    by J. M. S. Streubel, O. R. Karasu, I. M. Munoz, A. Neuner, E. N. Numanoglu, T. J. Macartney, E. Schiebel, J. Rouse, G. Pereira

    Centrioles maintain a characteristic length throughout the cell cycle, which is essential for the accurate functioning of centrosomes and ciliogenesis. The CP110-Cep97 complex acts as a cap on the distal end of the centriole, restricting microtubule extension. However, whether CP110-Cep97 alone or in conjunction with additional players regulates this process remains unclear. In this study, we identify the kinase Nek1 (NIMA-related kinase 1) as a key factor that works with the CP110-Cep97 complex to control centriole length. Nek1 localizes alongside CP110 and Cep97 at the distal end of the centriole and interacts with Cep97 and Cep78. Loss of Nek1 induces pronounced centriolar microtubule hyperelongation without displacement of the CP110-Cep97 complex, indicating that Nek1 restricts centriole extension through a distinct mechanism. Co-depletion of Nek1 and CP110, but not Cep78, further enhances the hyperelongation phenotype, demonstrating that Nek1 and CP110 pathways act in parallel to maintain centriole length in cycling cells. Notably, Nek1 is removed from the basal body during ciliogenesis in a Cep78-dependent manner, thereby linking Cep78 to the spatial regulation of Nek1 activity. Together, these findings establish Nek1 as an important safeguard that works with the CP110-Cep97 complex to ensure the structural integrity of centrioles.


  • Open Access

    CDKL5 kinase controls transcription‐coupled responses to DNA damage

    by Taran Khanam, Ivan Muñoz, Florian Weiland, Thomas Carroll, Michael Morgan, Barbara N Borsos, Vasiliki Pantazi, Meghan Slean, Miroslav Novak, Rachel Toth, et al.

    EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.


  • Open Access

    Epilepsy kinase CDKL5 is a DNA damage sensor which controls transcriptional activity at DNA breaks

    by Taran Khanam, Ivan Muñoz, Florian Weiland, Thomas Carroll, Barbara N Borsos, Vasiliki Pantazi, Meghan Slean, Miroslav Novak, Rachel Toth, Paul Appleton, et al.

    Mutation of the CDKL5 kinase gene leads to the seizure-prone neurodevelopmental condition CDD (CDKL5 deficiency disorder) and is the most common genetic cause of childhood epilepsy. However, the phospho-targets and roles of CDKL5 are poorly understood, especially in the nucleus. We reveal CDKL5 as a sensor of DNA damage in actively transcribed regions of the nucleus, which phosphorylates transcriptional regulators such as Elongin A (ELOA) on a specific consensus motif. Recruitment of CDKL5 and ELOA to DNA damage sites, and subsequent ELOA phosphorylation, requires both active transcription and synthesis of poly–ADP ribose to which CDKL5 can bind. Critically, CDKL5 is essential for transcriptional control at DNA breaks. Therefore, CDKL5 is a DNA damage-sensing regulator of transcription, with implications for CDKL5-related human diseases. One sentence summary: CDKL5 is a DNA damage-sensing kinase that modulates transcriptional activity near DNA breaks.

  • Open Access

    SINHCAF/FAM60A and SIN3A specifically repress HIF-2α expression

    by John Biddlestone, Michael Batie, Daniel Bandarra, Ivan Munoz, Sonia Rocha

    The SIN3A–HDAC (histone deacetylase) complex is a master transcriptional repressor, required for development but often deregulated in disease. Here, we report that the recently identified new component of this complex, SINHCAF (SIN3A and HDAC-associated factor)/FAM60A (family of homology 60A), links the SIN3A–HDAC co-repressor complex function to the hypoxia response. We show that SINHCAF specifically represses HIF-2α mRNA and protein expression, via its interaction with the transcription factor SP1 (specificity protein 1) and recruitment of HDAC1 to the HIF-2α promoter. SINHCAF control over HIF-2α results in functional cellular changes in in vitro angiogenesis and viability. Our analysis reveals an unexpected link between SINHCAF and the regulation of the hypoxia response.


  • Open Access

    RPA-Mediated Recruitment of the E3 Ligase RFWD3 Is Vital for Interstrand Crosslink Repair and Human Health

    by Laura Feeney, Ivan M. Muñoz, Christophe Lachaud, Rachel Toth, Paul L. Appleton, Detlev Schindler, John Rouse


  • Open Access

    Improved Genome Editing in Human Cell Lines Using the CRISPR Method

    by Ivan M. Munoz, Piotr Szyniarowski, Rachel Toth, John Rouse, Christophe Lachaud

    The Cas9/CRISPR system has become a popular choice for genome editing. In this system, binding of a single guide (sg) RNA to a cognate genomic sequence enables the Cas9 nuclease to induce a double-strand break at that locus. This break is next repaired by an error-prone mechanism, leading to mutation and gene disruption. In this study we describe a range of refinements of the method, including stable cell lines expressing Cas9, and a PCR based protocol for the generation of the sgRNA. We also describe a simple methodology that allows both elimination of Cas9 from cells after gene disruption and re-introduction of the disrupted gene. This advance enables easy assessment of the off target effects associated with gene disruption, as well as phenotype-based structure-function analysis. In our study, we used the Fan1 DNA repair gene as control in these experiments. Cas9/CRISPR-mediated Fan1 disruption occurred at frequencies of around 29%, and resulted in the anticipated spectrum of genotoxin hypersensitivity, which was rescued by re-introduction of Fan1.


  • Open Access

    Distinct functional roles for the SLX4 ubiquitin-binding UBZ domains mutated in Fanconi anemia

    by Christophe Lachaud, Dennis Castor, Karolina Hain, Ivan Muñoz, Jamie Wilson, Thomas J. MacArtney, Detlev Schindler, John Rouse

    Defects in SLX4, a scaffold for DNA repair nucleases, result in Fanconi anemia (FA), due to the defective repair of inter-strand DNA crosslinks (ICLs). Some FA patients have an SLX4 deletion removing two tandem UBZ4-type ubiquitin-binding domains that are implicated in protein recruitment to sites of DNA damage. Here, we show that human SLX4 is recruited to sites of ICL induction but that the UBZ-deleted form of SLX4 in cells from FA patients is not. SLX4 recruitment does not require either the ubiquitylation of FANCD2 or the E3 ligases RNF8, RAD18 and BRCA1. We show that the first (UBZ-1) but not the second UBZ domain of SLX4 binds to ubiquitin polymers, with a preference for K63-linked chains. Furthermore, UBZ-1 is required for SLX4 recruitment to ICL sites and for efficient ICL repair in murine fibroblasts. The SLX4 UBZ-2 domain does not bind to ubiquitin in vitro or contribute to ICL repair, but it is required for the resolution of Holliday junctions in vivo. These data shed light on SLX4 recruitment, and they point to the existence of currently unidentified ubiquitylated ligands and E3 ligases that are crucial for ICL repair.


  • Open Access

    Family with Sequence Similarity 60A (FAM60A) Protein Is a Cell Cycle-fluctuating Regulator of the SIN3-HDAC1 Histone Deacetylase Complex

    by Ivan M. Muñoz, Thomas MacArtney, Luis Sanchez-Pulido, Chris P. Ponting, Sonia Rocha, John Rouse


  • Modulation of Yeast Alkaline Cation Tolerance by Ypi1 Requires Calcineurin

    by Maribel Marquina, Asier González, Lina Barreto, Samuel Gelis, Iván Muñoz, Amparo Ruiz, Mari Carmen Álvarez, José Ramos, Joaquín Ariño

    Ypi1 was discovered as an essential protein able to act as a regulatory subunit of the Saccharomyces cerevisiae type 1 protein phosphatase Glc7 and play a key role in mitosis. We show here that partial depletion of Ypi1 causes lithium sensitivity and that high levels of this protein confer a lithium-tolerant phenotype to yeast cells. Remarkably, this phenotype was independent of the role of Ypi1 as a Glc7 regulatory subunit. Lithium tolerance in cells overexpressing Ypi1 was caused by a combination of increased efflux of lithium, mediated by augmented expression of the alkaline cation ATPase ENA1, and decreased lithium influx through the Trk1,2 high-affinity potassium transporters. Deletion of CNB1, encoding the regulatory subunit of the calcineurin phosphatase, blocked Ypi1-induced expression of ENA1, normalized Li+ fluxes, and abolished the Li+ hypertolerant phenotype of Ypi1-overexpressing cells. These results point to a complex role of Ypi1 on the regulation of cation homeostasis, largely mediated by the calcineurin phosphatase.